Molecular Partners AG (0QXX.L)

CHF 3.4

(-5.82%)

Inventory Summary of Molecular Partners AG

  • Molecular Partners AG's latest annual inventory in 2023 was - CHF , down 0.0% from previous year.
  • Molecular Partners AG's latest quarterly inventory in 2024 Q2 was - CHF , down 0.0% from previous quarter.
  • Molecular Partners AG reported annual inventory of - CHF in 2022, down -100.0% from previous year.
  • Molecular Partners AG reported annual inventory of 2.00 CHF in 2021, up 100.0% from previous year.
  • Molecular Partners AG reported quarterly inventory of - CHF for 2024 Q3, down 0.0% from previous quarter.
  • Molecular Partners AG reported quarterly inventory of - CHF for 2024 Q2, down 0.0% from previous quarter.

Annual Inventory Chart of Molecular Partners AG (2023 - 2013)

Historical Annual Inventory of Molecular Partners AG (2023 - 2013)

Year Inventory Inventory Growth
2023 - CHF 0.0%
2022 - CHF -100.0%
2021 2.00 CHF 100.0%
2020 -199 Thousand CHF 59.05%
2019 -486 Thousand CHF 78.8%
2018 -2.29 Million CHF 75.7%
2017 -9.43 Million CHF -943400100.0%
2016 1.00 CHF -100.0%
2015 126.47 Thousand CHF -66.69%
2014 379.67 Thousand CHF 0.0%
2013 - CHF 0.0%

Peer Inventory Comparison of Molecular Partners AG

Name Inventory Inventory Difference
Relief Therapeutics Holding AG 557 Thousand CHF 100.0%
Tecan Group AG 254.36 Million CHF 100.0%
Santhera Pharmaceuticals Holding AG 1.81 Million CHF 100.0%
Basilea Pharmaceutica AG 26.41 Million CHF 100.0%
Bachem Holding AG 340.98 Million CHF 100.0%
Siegfried Holding AG 431.93 Million CHF 100.0%